Literature DB >> 11356191

The protein kinase C-related kinase PRK2 interacts with the protein tyrosine phosphatase PTP-BL via a novel PDZ domain binding motif.

C Gross1, R Heumann, K S Erdmann.   

Abstract

Protein tyrosine phosphatase-basophil like (PTP-BL) is a large non-transmembrane protein tyrosine phosphatase implicated in the modulation of the cytoskeleton. Here we describe a novel interaction of PTP-BL with the protein kinase C-related kinase 2 (PRK2), a serine/threonine kinase regulated by the G-protein rho. This interaction is mediated by the PSD-95, Drosophila discs large, zonula occludens (PDZ)3 domain of PTP-BL and the extreme C-terminus of PRK2 as shown by yeast two-hybrid assays and coimmunoprecipitation experiments from transfected HeLa cells. In particular, we demonstrate that a conserved C-terminal cysteine of PRK2 is indispensable for the interaction with PTP-BL. In HeLa cells we demonstrate colocalization of both proteins in lamellipodia like structures. Interaction of PTP-BL with the rho effector kinase PRK2 gives further evidence for a possible function of PTP-BL in the regulation of the actin cytoskeleton.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11356191     DOI: 10.1016/s0014-5793(01)02401-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  19 in total

1.  The protein tyrosine phosphatase PTP-BL associates with the midbody and is involved in the regulation of cytokinesis.

Authors:  Lutz Herrmann; Thomas Dittmar; Kai S Erdmann
Journal:  Mol Biol Cell       Date:  2003-01       Impact factor: 4.138

Review 2.  PDZ domains-glue and guide.

Authors:  Marco van Ham; Wiljan Hendriks
Journal:  Mol Biol Rep       Date:  2003-06       Impact factor: 2.316

3.  Solution structure and backbone dynamics of the AF-6 PDZ domain/Bcr peptide complex.

Authors:  Quan Chen; Xiaogang Niu; Yingqi Xu; Jihui Wu; Yunyu Shi
Journal:  Protein Sci       Date:  2007-05-01       Impact factor: 6.725

4.  The transcriptional coactivator FHL2 transmits Rho signals from the cell membrane into the nucleus.

Authors:  Judith M Müller; Eric Metzger; Holger Greschik; Anja-Katrin Bosserhoff; Luka Mercep; Reinhard Buettner; Roland Schüle
Journal:  EMBO J       Date:  2002-02-15       Impact factor: 11.598

Review 5.  PTPN13/PTPL1: an important regulator of tumor aggressiveness.

Authors:  Gilles Freiss; Dany Chalbos
Journal:  Anticancer Agents Med Chem       Date:  2011-01       Impact factor: 2.505

6.  Rho GTPases regulate PRK2/PKN2 to control entry into mitosis and exit from cytokinesis.

Authors:  Anja Schmidt; Joanne Durgan; Ana Magalhaes; Alan Hall
Journal:  EMBO J       Date:  2007-03-01       Impact factor: 11.598

7.  Protein kinase N2 regulates AMP kinase signaling and insulin responsiveness of glucose metabolism in skeletal muscle.

Authors:  Maxwell A Ruby; Isabelle Riedl; Julie Massart; Marcus Åhlin; Juleen R Zierath
Journal:  Am J Physiol Endocrinol Metab       Date:  2017-07-18       Impact factor: 4.310

8.  Interaction of the protein tyrosine phosphatase PTPL1 with the PtdIns(3,4)P2-binding adaptor protein TAPP1.

Authors:  Wendy A Kimber; Maria Deak; Alan R Prescott; Dario R Alessi
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

9.  Missense polymorphisms of PTPRJ and PTPN13 genes affect susceptibility to a variety of human cancers.

Authors:  Yuichiro Mita; Yukiko Yasuda; Akiko Sakai; Hiromasa Yamamoto; Shinichi Toyooka; Mehmet Gunduz; Shunsuke Tanabe; Yoshio Naomoto; Mamoru Ouchida; Kenji Shimizu
Journal:  J Cancer Res Clin Oncol       Date:  2009-08-12       Impact factor: 4.553

10.  The tumour-associated antigen L6 (L6-Ag) is recruited to the tetraspanin-enriched microdomains: implication for tumour cell motility.

Authors:  Tamara Lekishvili; Elisa Fromm; Michelle Mujoomdar; Fedor Berditchevski
Journal:  J Cell Sci       Date:  2008-02-12       Impact factor: 5.285

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.